Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 08, 2021

SELL
$7.24 - $11.2 $16,652 - $25,760
-2,300 Closed
0 $0
Q1 2021

Jun 17, 2021

BUY
$8.05 - $20.78 $18,515 - $47,794
2,300 New
2,300 $20,000
Q3 2018

Sep 07, 2021

SELL
$1.38 - $2.27 $96,304 - $158,414
-69,786 Closed
0 $0
Q1 2018

Sep 07, 2021

SELL
$1.19 - $2.17 $126 - $230
-106 Reduced 0.15%
69,786 $126,000
Q3 2017

Sep 07, 2021

BUY
$1.2 - $2.84 $83,870 - $198,493
69,892
69,892 $185,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $54.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.